Thursday, April 9, 2026
ADVT 
National

Canada plans to launch 'anti-racism' ads

Darpan News Desk The Canadian Press, 07 Jul, 2021 12:43 PM
  • Canada plans to launch 'anti-racism' ads

The federal government plans to launch a national ad campaign aimed at making more white Canadians knowledgeable about systemic racism.

Launching a public education and awareness campaign is part of the Liberal government's anti-racism strategy.

That strategy says $3.3 million will be spent on a marketing effort.

Details of what Canadian Heritage is looking for in such a campaign, set to launch later this year, are included in documents posted on the government's procurement website.

The department says its target audience is "non-racialized Canadian middle-aged adults" — defined as between 30 and 44 years old — living in any rural or urban area.

It specifically points out that includes adults living in places such as Hamilton, Thunder Bay and Quebec, considered to be "racism hot spots" because of the high volume of police-reported hate crimes.

The department says the campaign's goal is to get more Canadians fighting systemic racism by making them aware of its impacts through marketing, social media and public engagement.

"In this COVID-19 context, Canadians are face-to-face with a unique opportunity to reimagine the social contract … in ways that place anti-racism, equity, reconciliation and human rights at the heart of the recovery process," the documents read.

The department cites how data shows that during the COVID-19 pandemic, Indigenous, Black, Asian, Muslim and Jewish communities faced more discrimination and hate crimes.

The issue of systemic racism was brought to the forefront last May after the murder of George Floyd, a Black man in Minneapolis, by former police officer Derek Chauvin.

His death sparked protests and rallies across Canada calling out racism in this country too.

MORE National ARTICLES

B.C. helps fund new ALS research position at UBC

B.C. helps fund new ALS research position at UBC
The province says the dedicated clinician and scientist will support patients living with the disease through care and research for a cure, with the goal of increasing patients' access to local clinical trials.

B.C. helps fund new ALS research position at UBC

Singh calls for halt on arms sales to Israel

Singh calls for halt on arms sales to Israel
 Prime Minister Justin Trudeau responded by asking all sides to protect civilians and end the violence, saying rocket attacks against Israel as well as violence at an iconic mosque are "unacceptable."

Singh calls for halt on arms sales to Israel

Forces see little progress in drive to add women

Forces see little progress in drive to add women
Then-defence chief general Jonathan Vance in February 2016 set a goal of having women represent one-quarter of the Canadian Armed Forces' members over the next decade. At the time, women accounted for 15 per cent of military personnel.

Forces see little progress in drive to add women

Business leaders in U.S., Canada join Line 5 fight

Business leaders in U.S., Canada join Line 5 fight
The Canadian and U.S. chambers of commerce joined forces with their counterparts in Ohio, Michigan and Wisconsin by filing a joint brief in court to argue against Gov. Gretchen Whitmer's bid to shut down the cross-border pipeline.

Business leaders in U.S., Canada join Line 5 fight

Canada-U.S. spat over right whale prompts proposal

Canada-U.S. spat over right whale prompts proposal
A Canada-U.S. spat over who is responsible for the recent death of a critically endangered right whale has prompted a senior Canadian official to suggest there's got to be a better way of settling such disputes.

Canada-U.S. spat over right whale prompts proposal

Questions remain about AstraZeneca shot's future

Questions remain about AstraZeneca shot's future
Questions remained Wednesday about the future of the Oxford-AstraZeneca vaccine in Canada as the federal government prepared to receive hundreds of thousands of doses while provinces limited use of the shot.

Questions remain about AstraZeneca shot's future